Skip to main content

Find Clinical Trials

Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Melanoma Molecular Profiling Analysis

NCT00889980

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas

NCT04423094

Conditions: Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations: Uh Montpellier Montpellier, France

View Trial Details

Completed

Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors

NCT02502708

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +24 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Arnold Palmer Hospital for Children Orlando, Florida, United States

Children's Heathcare of Atlanta Atlanta, Georgia, United States

Augusta University Augusta, Georgia, United States

View Trial Details

Completed

Long Term Survivors of High-grade Glioma and Their Caregivers

NCT02965144

Conditions: Behavior, Behavioral Symptoms, Brain Diseases, +13 more
Locations: University hospital of Copenhagen, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

NCT03112694

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Cancer Center of Kansas Wichita, Kansas, United States

Ochsner Clinic Foundation New Orleans, Louisiana, United States

Mercy Medical Center Baltimore, Maryland, United States

View Trial Details

Completed

Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)

NCT01866319

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Not specified

View Trial Details

Completed

A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma

NCT01897116

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors

NCT01331135

Conditions: Adenocarcinoma, Astrocytoma, Atypical Teratoid/Rhabdoid Tumor, +56 more
Locations: Children's Healthcare of Atlanta Atlanta, Georgia, United States

View Trial Details

Completed

Vaccine Treatment for Advanced Malignant Melanoma

NCT00300612

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

NCT00333502

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +56 more
Locations: Virginia G. Piper Cancer Center Scottsdale, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

San Juan Oncology Associates Farmington, New Mexico, United States

View Trial Details